Lipum: Interview with analyst Kevin Sule (video)
Redeye recently initiated coverage of Lipum, a Swedish biotech company developing novel therapeutics for chronic inflammatory diseases. Analyst Kevin Sule talks us through the investment case.
RR
Redaktionen Redeye
Disclosures and disclaimers